What are the landmark trials in hypertension management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Landmark Trials in Hypertension Management

The most important landmark trials in hypertension management include ALLHAT, SPRINT, ACCORD, ACCOMPLISH, and HYVET, which have shaped current treatment guidelines by demonstrating the efficacy of various antihypertensive medications and optimal blood pressure targets for reducing cardiovascular morbidity and mortality.

Key Landmark Trials

ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

  • Largest randomized trial of antihypertensive drugs (42,418 patients) comparing chlorthalidone (diuretic), amlodipine (calcium channel blocker), and lisinopril (ACE inhibitor) 1
  • Key findings:
    • No difference in primary outcome (fatal CHD or nonfatal MI) between treatment groups
    • Thiazide diuretics were superior in preventing heart failure compared to amlodipine and lisinopril
    • Established thiazide diuretics as preferred first-line agents due to efficacy and cost-effectiveness 2, 3

SPRINT (Systolic Blood Pressure Intervention Trial)

  • Compared intensive BP treatment (target <120 mmHg) vs standard treatment (target <140 mmHg) in high-risk non-diabetic patients 2, 4
  • Key findings:
    • Demonstrated cardiovascular benefit from intensive treatment to SBP goal <120 mmHg
    • Showed 25% reduction in primary composite outcome and 27% reduction in all-cause mortality
    • Led to lower BP targets in subsequent guidelines 2

ACCORD (Action to Control Cardiovascular Risk in Diabetes)

  • Evaluated intensive vs standard BP control in patients with type 2 diabetes 2
  • Key findings:
    • Did not show statistically significant reduction in primary cardiovascular composite outcome
    • Trial was underpowered and complicated by factorial design
    • Meta-analysis with SPRINT suggested consistent findings between trials 2

ACCOMPLISH (Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension)

  • First trial to compare outcomes of two fixed-dose combination therapies: benazepril/amlodipine vs benazepril/hydrochlorothiazide 5, 6
  • Key findings:
    • Demonstrated superiority of ACE inhibitor/CCB combination over ACE inhibitor/diuretic combination
    • Influenced guidelines regarding combination therapy approaches

HYVET (Hypertension in the Very Elderly Trial)

  • Focused on treatment of hypertension in patients over 80 years of age 2
  • Key findings:
    • Demonstrated benefit of antihypertensive treatment in reducing stroke and mortality in the very elderly
    • Showed that BP-lowering therapy reduces risk of death in frail older adults

Impact on Treatment Guidelines

Blood Pressure Targets

  • Evolution of targets based on trial evidence:
    • JNC 7 recommended <140/90 mmHg for most patients
    • After SPRINT, ACC/AHA 2017 guidelines lowered target to <130/80 mmHg for most adults 2
    • For older adults (≥65 years), current guidelines recommend SBP goal <130 mmHg for ambulatory, community-dwelling individuals 2

First-Line Medication Selection

  • Thiazide diuretics remain preferred first-line agents based on ALLHAT findings 7, 1
  • For specific populations:
    • Black patients: Thiazide diuretics and calcium channel blockers are more effective 7
    • Diabetic patients: ACE inhibitors or ARBs preferred 7
    • CKD patients: ACE inhibitors or ARBs preferred 7

Combination Therapy Approaches

  • ACCOMPLISH trial demonstrated the value of specific combination therapies 5, 6
  • Most patients with hypertension require multiple medications to achieve target BP 7
  • Effective combinations include:
    • Thiazide diuretic + ACE inhibitor/ARB
    • CCB + ACE inhibitor/ARB
    • CCB + thiazide diuretic 7

Clinical Implications and Controversies

Blood Pressure Measurement Method

  • SPRINT used automated office BP measurement with patient alone, which may yield lower readings than traditional methods 4
  • This raises questions about how to apply SPRINT findings in typical clinical settings

Target BP in Special Populations

  • Diabetes: Despite ACCORD results, guidelines recommend treatment initiation at ≥130/80 mmHg with goal <130/80 mmHg 2
  • CKD: Treatment threshold at ≥130/80 mmHg with goal <130/80 mmHg 2
  • Elderly: Target <130 mmHg for ambulatory older adults, with more cautious approach in frail patients with high comorbidity burden 2

J-Curve Phenomenon

  • Some evidence suggests potential harm with very low BP targets in certain populations
  • Retrospective analyses have suggested a J-curve for cardiovascular events, particularly in diabetic patients and those with coronary disease 2
  • Careful titration and monitoring is essential, especially in older adults 2

The landmark trials in hypertension management have progressively refined our understanding of optimal treatment approaches, with newer trials building on previous evidence to improve cardiovascular outcomes and reduce mortality in hypertensive patients.

References

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

7
Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the appropriate management for a 44-year-old patient with a history of hypertension, hyperlipidemia, and status post (after) prostatectomy presenting for a yearly medical examination?
What is the cause of hives in a 63-year-old patient with tachycardia and Hypertension (HTN) taking Chlorthalidone and Diltiazem?
What is the next step to manage a 68-year-old female patient with hypertension (HTN) whose blood pressure remains elevated at 158/110 mmHg despite recently increased lisinopril (angiotensin-converting enzyme inhibitor) to 40 mg?
What is the first-line anti-hypertensive medication, including dosage and frequency, for a 40-year-old woman with hypertension (high blood pressure), hyperprolactinemia (elevated prolactin levels), and normal thyroid function (normal T3 and T4 levels), presenting with a blood pressure of 160/90 mmHg?
How to optimize antihypertensive therapy in a 43-year-old female with Hypertension (elevated Blood Pressure), mild Left Ventricular Hypertrophy (LVH), and Diabetes Mellitus (DM), currently on Lisinopril (Angiotensin-Converting Enzyme Inhibitor) 20 mg and Hydrochlorothiazide (HCTZ) (Thiazide Diuretic) 25 mg, after discontinuation of Amlodipine (Calcium Channel Blocker) due to peripheral edema?
How are levothyroxine (T4) dosage adjustments typically made?
Why do patients with iron deficiency anemia (IDA) often have thrombocytosis (high platelet count)?
What are the guidelines for managing hypertension based on landmark trials?
What is the evaluation and management approach for emphysematous pyelonephritis?
What are the recommended initial screening tools and treatment approaches for patients presenting with symptoms of depression or anxiety, such as using the Patient Health Questionnaire (PHQ)-9 and Generalized Anxiety Disorder (GAD)-7 forms?
What are the implications of elevated ferritin (iron storage protein) levels with normal iron and slightly low transferrin (iron-binding protein) levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question